Universal Health Services - UHS Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $123.00
  • Forecasted Upside: 13.91 %
  • Number of Analysts: 13
  • Breakdown:
  • 5 Sell Ratings
  • 3 Hold Ratings
  • 5 Buy Ratings
  • 0 Strong Buy Ratings
$107.98
▼ -0.28 (-0.26%)

This chart shows the closing price for UHS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Universal Health Services Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for UHS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for UHS

Analyst Price Target is $123.00
▲ +13.91% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Universal Health Services in the last 3 months. The average price target is $123.00, with a high forecast of $169.00 and a low forecast of $90.00. The average price target represents a 13.91% upside from the last price of $107.98.

This chart shows the closing price for UHS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 13 investment analysts is to hold stock in Universal Health Services. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 2 hold ratings
  • 5 sell ratings
2/25/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 4 sell ratings
5/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 4 sell ratings
8/24/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 5 sell ratings
11/22/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 4 sell ratings
2/20/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 3 hold ratings
  • 4 sell ratings
5/21/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 5 sell ratings
7/20/2022
  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 5 sell ratings
8/19/2022

Latest Recommendations

  • 0 strong buy ratings
  • 5 buy ratings
  • 3 hold ratings
  • 5 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/9/2022CowenLower Target$119.00Low
7/29/2022BarclaysLower Target$133.00 ➝ $115.00Low
7/28/2022SVB LeerinkBoost TargetMarket Perform$103.00 ➝ $111.00Low
7/27/2022StephensBoost TargetOutperform$110.00Low
7/27/2022Deutsche Bank AktiengesellschaftLower Target$160.00 ➝ $130.00Low
7/26/2022UBS GroupBoost Target$105.00Low
7/19/2022Credit Suisse GroupSet Target$135.00Low
7/15/2022SVB LeerinkLower TargetMarket Perform$108.00 ➝ $103.00Low
7/12/2022The Goldman Sachs GroupLower TargetSell$125.00 ➝ $110.00N/A
7/6/2022BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$133.00 ➝ $90.00N/A
7/4/2022StephensLower Target$105.00N/A
7/1/2022Credit Suisse GroupLower TargetOutperform$156.00 ➝ $141.00Low
7/1/2022MizuhoLower TargetBuy$153.00 ➝ $121.00Low
6/30/2022SVB LeerinkLower TargetMarket Perform$132.00 ➝ $108.00Low
6/16/2022Loop CapitalInitiated CoverageHold$115.00High
6/3/2022Credit Suisse GroupLower Target$156.00Low
5/3/2022MizuhoLower Target$164.00 ➝ $153.00Low
4/28/2022Wells Fargo & CompanyLower Target$139.00 ➝ $118.00Low
4/27/2022Royal Bank of CanadaLower Target$149.00 ➝ $130.00Low
4/27/2022Credit Suisse GroupLower Target$172.00 ➝ $158.00Medium
3/28/2022Wells Fargo & CompanyInitiated CoverageUnderweight$139.00Low
3/7/2022UBS GroupBoost TargetSell$124.00 ➝ $134.00Low
3/3/2022MizuhoBoost TargetBuy$151.00 ➝ $164.00Low
3/1/2022CitigroupBoost Target$162.00 ➝ $167.00High
2/28/2022SVB LeerinkBoost TargetMarket Perform$136.00 ➝ $139.00Low
2/27/2022Seaport Res PtnDowngradeBuy ➝ NeutralHigh
1/7/2022SVB LeerinkBoost TargetMarket Perform$132.00 ➝ $136.00Low
12/21/2021BarclaysLower TargetUnderweight$160.00 ➝ $141.00Medium
11/3/2021CitigroupLower TargetPositive ➝ Buy$188.00 ➝ $160.00High
10/29/2021MizuhoLower TargetBuy$178.00 ➝ $151.00High
10/27/2021SVB LeerinkLower TargetMarket Perform$140.00 ➝ $132.00Low
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$140.00Low
9/23/2021UBS GroupInitiated CoverageSell$136.00High
9/9/2021CowenInitiated CoverageOutperform$169.00Medium
9/8/2021The Goldman Sachs GroupDowngradeNeutral ➝ Sell$155.00 ➝ $150.00High
8/12/2021BarclaysDowngradeOverweight ➝ Underweight$170.00 ➝ $156.00Low
7/28/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$160.00 ➝ $185.00Low
7/28/2021MizuhoBoost TargetBuy$168.00 ➝ $178.00Low
7/28/2021CitigroupBoost TargetBuy$170.00 ➝ $188.00Low
7/27/2021BarclaysBoost TargetOverweight$160.00 ➝ $170.00High
7/9/2021Seaport Res PtnReiterated RatingBuyMedium
6/10/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform$160.00 ➝ $165.00Low
5/5/2021MizuhoBoost TargetBuy$151.00 ➝ $168.00Low
4/28/2021Royal Bank of CanadaBoost TargetOutperform$150.00 ➝ $160.00Medium
4/19/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$145.00 ➝ $160.00Low
3/14/2021JPMorgan Chase & Co.Reiterated RatingSell$115.00Medium
3/2/2021CitigroupLower Target$162.00 ➝ $151.00Low
1/5/2021Deutsche Bank AktiengesellschaftBoost TargetBuy$135.00 ➝ $145.00N/A
1/5/2021Bank of AmericaDowngradeNeutral ➝ Underperform$144.00N/A
12/18/2020MizuhoBoost TargetBuy$130.00 ➝ $151.00High
12/15/2020The Goldman Sachs GroupInitiated CoverageNeutral$149.00Medium
11/11/2020Piper SandlerBoost TargetNeutral$117.00 ➝ $139.00Medium
11/2/2020Credit Suisse GroupBoost TargetOutperform$140.00 ➝ $145.00Medium
9/21/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$138.00 ➝ $115.00High
7/30/2020Royal Bank of CanadaReiterated RatingBuyLow
7/29/2020Piper SandlerBoost TargetNeutral$113.00 ➝ $117.00Medium
7/29/2020Credit Suisse GroupBoost TargetOutperform$139.00 ➝ $140.00Medium
6/9/2020BarclaysUpgradeEqual Weight ➝ Overweight$138.00High
5/29/2020MizuhoLower TargetBuy$136.00 ➝ $130.00Medium
4/30/2020Royal Bank of CanadaReiterated RatingBuyHigh
4/30/2020UBS GroupLower TargetBuy$150.00 ➝ $133.00High
4/29/2020Deutsche Bank AktiengesellschaftLower TargetBuy$165.00 ➝ $135.00High
4/28/2020CitigroupLower TargetBuy$157.00 ➝ $128.00High
4/23/2020Piper SandlerLower TargetNeutral$141.00 ➝ $113.00High
3/23/2020Bank of AmericaDowngradeBuy ➝ Neutral$182.00 ➝ $104.00High
3/2/2020JPMorgan Chase & Co.Lower TargetNeutral$164.00 ➝ $155.00High
2/28/2020Robert W. BairdBoost TargetOutperform$160.00 ➝ $165.00High
2/28/2020UBS GroupLower TargetBuy$158.00 ➝ $150.00High
2/28/2020StephensLower TargetEqual Weight$153.00 ➝ $151.00High
2/28/2020BarclaysReiterated RatingHold$145.00High
1/3/2020Deutsche Bank AktiengesellschaftInitiated CoverageBuy$140.00Low
12/20/2019JPMorgan Chase & Co.Boost TargetNeutral$159.00 ➝ $164.00Medium
7/31/2019Morgan StanleyBoost TargetEqual Weight$135.00 ➝ $146.00Low
7/30/2019Royal Bank of CanadaBoost TargetOutperform$165.00Low
7/29/2019Credit Suisse GroupBoost TargetOutperform$150.00 ➝ $170.00Low
7/26/2019BarclaysSet TargetHold$145.00N/A
7/26/2019Bank of AmericaBoost TargetBuy ➝ Buy$158.00 ➝ $165.00Low
6/7/2019UBS GroupReiterated RatingBuy$151.00Medium
4/29/2019BMO Capital MarketsLower TargetMarket Perform$138.00Medium
4/17/2019BarclaysLower TargetEqual Weight ➝ Equal Weight$136.00 ➝ $130.00Medium
3/5/2019BMO Capital MarketsBoost TargetMarket Perform$146.00Low
3/4/2019UBS GroupBoost TargetBuy ➝ Buy$156.00 ➝ $161.00Low
3/4/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$147.00High
3/1/2019Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$140.00 ➝ $160.00Low
3/1/2019BarclaysBoost TargetEqual Weight ➝ Equal Weight$130.00 ➝ $136.00Low
3/1/2019Wells Fargo & CompanyBoost TargetOutperform ➝ Outperform$147.00 ➝ $150.00Low
3/1/2019CitigroupBoost TargetBuy ➝ Buy$140.00 ➝ $164.00Low
2/28/2019MizuhoSet TargetIn-Line ➝ Buy$150.00Medium
2/28/2019Robert W. BairdBoost TargetOutperform ➝ Outperform$140.00 ➝ $145.00Medium
1/14/2019StephensInitiated CoverageEqual ➝ Equal Weight$134.00Medium
1/3/2019Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$140.00Medium
12/13/2018The Goldman Sachs GroupDowngradeNeutral ➝ Sell$125.00High
11/15/2018UBS GroupInitiated CoverageBuy ➝ Buy$156.00High
10/29/2018SVB LeerinkLower TargetOutperform$140.00 ➝ $135.00Medium
10/29/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$134.00 ➝ $130.00Medium
10/29/2018BarclaysLower TargetEqual Weight ➝ Equal Weight$135.00 ➝ $130.00Medium
10/29/2018CitigroupLower TargetBuy ➝ Buy$145.00 ➝ $140.00Low
9/18/2018Bank of AmericaUpgradeNeutral ➝ Buy$128.00 ➝ $155.00High
9/5/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$122.00 ➝ $134.00Low
8/14/2018BarclaysInitiated CoverageEqual Weight$135.00Low
8/1/2018BMO Capital MarketsDowngradeOutperform ➝ Market Perform$130.00Low
7/27/2018Morgan StanleyBoost TargetEqual Weight ➝ Equal Weight$120.00 ➝ $122.00Low
7/18/2018The Goldman Sachs GroupDowngradeBuy ➝ Neutral$120.00Medium
4/27/2018Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$124.00 ➝ $120.00Low
3/6/2018Deutsche Bank AktiengesellschaftBoost TargetBuy ➝ Buy$132.00 ➝ $138.00Low
3/6/2018Robert W. BairdReiterated RatingBuy$122.00 ➝ $140.00Low
3/5/2018Credit Suisse GroupReiterated RatingOutperform ➝ Outperform$135.00 ➝ $140.00Low
3/2/2018Royal Bank of CanadaReiterated RatingBuy$136.00High
3/2/2018Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$122.00 ➝ $124.00High
3/2/2018BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$125.00 ➝ $130.00High
3/1/2018StephensSet TargetHold$120.00High
1/30/2018Wells Fargo & CompanyInitiated CoverageOutperform ➝ Outperform$144.00High
1/24/2018MizuhoSet TargetBuy$137.00Low
1/4/2018Royal Bank of CanadaReiterated RatingBuy$134.00Medium
1/3/2018The Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$137.00High
1/3/2018Piper Jaffray CompaniesDowngradeOverweight ➝ Neutral$147.00High
12/19/2017Credit Suisse GroupReiterated RatingOutperform$125.00 ➝ $135.00Low
12/12/2017CitigroupUpgradeNeutral ➝ BuyMedium
11/10/2017Credit Suisse GroupLower TargetOutperform$126.00 ➝ $125.00N/A
11/2/2017Credit Suisse GroupInitiated CoverageOutperform$126.00N/A
10/27/2017Royal Bank of CanadaReiterated RatingBuy$126.00N/A
10/27/2017CitigroupLower TargetNeutral$126.00 ➝ $114.00N/A
10/27/2017Piper Jaffray CompaniesReiterated RatingBuy$117.00N/A
10/27/2017Robert W. BairdReiterated RatingBuy$122.00N/A
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$125.00N/A
10/11/2017StephensInitiated CoverageEqual ➝ Equal Weight$120.00N/A
10/3/2017Royal Bank of CanadaReiterated RatingBuy$147.00Low
9/22/2017SVB LeerinkBoost TargetOutperform$130.00 ➝ $132.00Low
9/7/2017KeyCorpReiterated RatingBuy$127.00Low
8/29/2017Royal Bank of CanadaReiterated RatingBuy$147.00High
(Data available from 8/19/2017 forward)

News Sentiment Rating

0.15 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 3 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
1/21/2022
  • 0 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/20/2022
  • 6 very positive mentions
  • 32 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/22/2022
  • 5 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/21/2022
  • 0 very positive mentions
  • 35 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
5/21/2022
  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/20/2022
  • 3 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
7/20/2022
  • 5 very positive mentions
  • 38 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
8/19/2022

Current Sentiment

  • 5 very positive mentions
  • 38 positive mentions
  • 5 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Universal Health Services logo
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Read More

Today's Range

Now: $107.98
Low: $107.52
High: $108.64

50 Day Range

MA: $107.05
Low: $100.27
High: $112.64

52 Week Range

Now: $107.98
Low: $98.63
High: $158.28

Volume

995,506 shs

Average Volume

763,819 shs

Market Capitalization

$7.88 billion

P/E Ratio

11.00

Dividend Yield

0.74%

Beta

1.18

Frequently Asked Questions

What sell-side analysts currently cover shares of Universal Health Services?

The following equities research analysts have issued research reports on Universal Health Services in the last twelve months: Barclays PLC, BMO Capital Markets, Citigroup Inc., Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Loop Capital, Mizuho, Royal Bank of Canada, Seaport Res Ptn, Stephens, StockNews.com, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Wells Fargo & Company.
View the latest analyst ratings for UHS.

What is the current price target for Universal Health Services?

15 Wall Street analysts have set twelve-month price targets for Universal Health Services in the last year. Their average twelve-month price target is $123.00, suggesting a possible upside of 13.9%. Cowen Inc has the highest price target set, predicting UHS will reach $169.00 in the next twelve months. BMO Capital Markets has the lowest price target set, forecasting a price of $90.00 for Universal Health Services in the next year.
View the latest price targets for UHS.

What is the current consensus analyst rating for Universal Health Services?

Universal Health Services currently has 5 sell ratings, 3 hold ratings and 5 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in UHS, but not buy more shares or sell existing shares.
View the latest ratings for UHS.

What other companies compete with Universal Health Services?

How do I contact Universal Health Services' investor relations team?

Universal Health Services' physical mailing address is 367 S GULPH RD, KING OF PRUSSIA PA, 19406. The health services provider's listed phone number is (610) 768-3300 and its investor relations email address is [email protected] The official website for Universal Health Services is www.uhsinc.com. Learn More about contacing Universal Health Services investor relations.